AGM
XFOR icon

Alpine Global Management’s X4 Pharmaceuticals XFOR Stock Holding History

Alpine Global Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-563
Closed -$110K – 377
2021
Q2 		$110K Buy
+563
New +$142K 0.02% 264

Other funds holding XFOR

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Alpine Global Management's XFOR Position: Q3 2021 in Review

Alpine Global Management sold out of X4 Pharmaceuticals (XFOR) in Q3 2021, closing a stake of 563 shares — an estimated $110K sold.

Alpine Global Management first reported a position in XFOR in Q2 2021 and held it in 1 quarter. The position peaked at $110K in Q2 2021. 51 funds tracked by Wall St. Rank hold XFOR as of Q3 2021.

  • Alpine Global Management reported no remaining X4 Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Alpine Global Management sold 563 X4 Pharmaceuticals shares in Q3 2021, an estimated $110K.
  • Alpine Global Management first reported a position in X4 Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Alpine Global Management's X4 Pharmaceuticals position peaked at $110K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2021.

Based on Alpine Global Management's 13F filing for Q3 2021, filed 12 Nov 2021.